beta

AERI

Aerie Pharmaceuticals Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Market Cap: 880 Million

Primary Exchange: NASDAQ/NMS (GLOBAL MARKET)

Website: http://www.aeriepharma.com/

Shares Outstanding: 46.9 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 1.03409877613488

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 837 trading days

From: 2018-07-19 To: 2021-03-05

Lowest Point:

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences

via: Business Wire at 2019-06-11 03:30:00:000

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye today announced that … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud